These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34953597)

  • 21. [Treatment strategy for immunoglobulin light chain amyloidosis].
    Fuchida SI
    Rinsho Ketsueki; 2021; 62(8):1160-1166. PubMed ID: 34497203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful long-term outcome of the first combined heart and kidney transplant in a patient with systemic Al amyloidosis.
    Audard V; Matignon M; Weiss L; Remy P; Pardon A; Haioun C; Belhadj K; Salomon L; Hillon ML; Sahali D; Vermes E; Lang P; Grimbert P
    Am J Transplant; 2009 Jan; 9(1):236-40. PubMed ID: 19067666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature].
    Adam Z; Krejcí M; Pour L; Stepánková S; Cermáková Z; Voska L; Teplan V; Krivanová A; Hájek R; Mayer J
    Vnitr Lek; 2009 Nov; 55(11):1089-96. PubMed ID: 20017442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bilateral kidney infarction due to primary Al amyloidosis: a first case report.
    Mihout F; Joseph L; Brocheriou I; Leblond V; Varnous S; Ronco P; Plaisier E
    Medicine (Baltimore); 2015 May; 94(17):e777. PubMed ID: 25929920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emerging therapy in light-chain and acquired transthyretin-related amyloidosis: an Italian single-centre experience in heart transplantation.
    Di Nora C; Sponga S; Ferrara V; Patriarca F; Fanin R; Nalli C; Lechiancole A; Vendramin I; Livi U
    J Cardiovasc Med (Hagerstown); 2021 Apr; 22(4):261-267. PubMed ID: 33633041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is there still a place for autologous stem cell transplantation in systemic AL amyloidosis with severe renal disease?
    Bridoux F; Javaugue V; Fermand JP; Jaccard A
    Nephrol Dial Transplant; 2016 Aug; 31(8):1199-202. PubMed ID: 26908764
    [No Abstract]   [Full Text] [Related]  

  • 27. Kidney and liver involvement in monoclonal light chain disorders.
    Pozzi C; Locatelli F
    Semin Nephrol; 2002 Jul; 22(4):319-30. PubMed ID: 12118397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequential heart and autologous stem cell transplantation for systemic AL amyloidosis.
    Gillmore JD; Goodman HJ; Lachmann HJ; Offer M; Wechalekar AD; Joshi J; Pepys MB; Hawkins PN
    Blood; 2006 Feb; 107(3):1227-9. PubMed ID: 16210334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stem cell transplantation for immunoglobulin light chain amyloidosis.
    Sher T; Gertz MA
    Curr Probl Cancer; 2017; 41(2):129-137. PubMed ID: 28457657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heart transplantation and end-stage cardiac amyloidosis: a review and approach to evaluation and management.
    Estep JD; Bhimaraj A; Cordero-Reyes AM; Bruckner B; Loebe M; Torre-Amione G
    Methodist Debakey Cardiovasc J; 2012; 8(3):8-16. PubMed ID: 23227279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome of patients with systemic light chain amyloidosis with concurrent renal and cardiac involvement.
    Badar T; Cornelison AM; Shah ND; Bashir Q; Parmar S; Patel K; Hosing C; Popat U; Weber DM; Thomas SK; Shah JJ; Orlowski RZ; Champlin RE; Qazilbash MH
    Eur J Haematol; 2016 Oct; 97(4):342-7. PubMed ID: 26773409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autologous Stem Cell Transplantation in Patients With Primary Systemic Amyloidosis: Experience of a Tertiary Hospital.
    Domínguez-Muñoz MA; Calderón-Cabrera C; Martino-Galiana ML; Martín-Sánchez J
    Transplant Proc; 2015 Nov; 47(9):2661-4. PubMed ID: 26680066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of survival to orthotopic heart transplant in patients with light chain amyloidosis.
    Gray Gilstrap L; Niehaus E; Malhotra R; Ton VK; Watts J; Seldin DC; Madsen JC; Semigran MJ
    J Heart Lung Transplant; 2014 Feb; 33(2):149-56. PubMed ID: 24200511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent Advances in the Diagnosis, Risk Stratification, and Management of Systemic Light-Chain Amyloidosis.
    Vaxman I; Gertz M
    Acta Haematol; 2019; 141(2):93-106. PubMed ID: 30650422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The utility of repeat kidney biopsy in systemic immunoglobulin light chain amyloidosis.
    Angel-Korman A; Jaberi A; Sanchorawala V; Havasi A
    Amyloid; 2020 Mar; 27(1):17-24. PubMed ID: 31595786
    [No Abstract]   [Full Text] [Related]  

  • 36. Cardiac transplantation using extended-donor criteria organs for systemic amyloidosis complicated by heart failure.
    Maurer MS; Raina A; Hesdorffer C; Bijou R; Colombo P; Deng M; Drusin R; Haythe J; Horn E; Lee SH; Marboe C; Naka Y; Schulman L; Scully B; Shapiro P; Prager K; Radhakrishnan J; Restaino S; Mancini D
    Transplantation; 2007 Mar; 83(5):539-45. PubMed ID: 17353770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of consolidation therapy post autologous stem cell transplant in patients with light chain amyloidosis.
    Al Saleh AS; Sidiqi MH; Sidana S; Muchtar E; Dispenzieri A; Dingli D; Lacy MQ; Warsame RM; Gonsalves WI; Kourelis TV; Hogan WJ; Hayman SR; Wolf RC; Kapoor P; Buadi FK; Kumar SK; Gertz MA
    Am J Hematol; 2019 Oct; 94(10):1066-1071. PubMed ID: 31273808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical features and outcomes of renal amyloidosis in Hong Kong.
    Lin RCC; Yuen SK; Cheung SF; Tang HL; Fung SKS
    Nephrology (Carlton); 2022 Nov; 27(11):869-876. PubMed ID: 36054582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AL amyloidosis in a young adult: remission with autologous stem cell transplantation.
    Golmia RP; Bello IC; Rosseto E; Guerra JC; Mangueira C; Scheinberg MA
    Rev Bras Reumatol; 2010; 50(5):603-8. PubMed ID: 21125195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current and emerging views and treatments of systemic immunoglobulin light-chain (Al) amyloidosis.
    Comenzo RL
    Contrib Nephrol; 2007; 153():195-210. PubMed ID: 17075231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.